(Q43946122)
Statements
Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures (English)
Tam CM
Chan SL
Kam KM
Goodall RL
1 January 2002
scientific article